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Heterologous Expression of WT and Mutant Photoreceptor Peripherin/rds in
Madin Darby Canine Kidney Cells: an Assessment of Fusogenic Function
Abstract
Peripherin/rds is proposed to function as a fusion protein within the rod outer segment and a fusion
domain has been mapped to amino acids 311–325 within the C-terminus. To map regions within
peripherin/rds required for membrane fusion a series of C-terminal mutants was analyzed. Madin Darby
canine kidney cells were transiently transfected with an Xpress or FLAG epitope tagged peripherin/rds
(wt) and three mutants of peripherin/rds. The mutants selected were a P296T mutant (replacement of the
proline at position 296 with a threonine) and two C-terminal deletion mutants (one lacking the terminal 10
amino acids, Δ10 and one lacking the terminal 50 amino acids, Δ50). The wt protein, the P296T and Δ10
mutants were detected on SDS–PAGE as 84 kDa dimers, that resolved into 38–42 kDa monomers under
reducing conditions. The Δ50 mutant showed a slightly increased mobility. The cellular localization of
mutants differed from that of wt peripherin/rds. The wt Xpress-human and wt FLAG-bovine peripherin/rds
were localized to both intracellular and plasma membranes. In contrast, the C-terminal deletion mutants
were localized only to the intracellular membrane. The P296T mutant presented a still different pattern:
initially the protein localized to intracellular membranes. Upon confluence, however, the localization
appeared to become predominantly plasma membrane. To assess the fusion activity of the proteins, the
cell membranes were fractionated using sucrose density gradient centrifugation and the various fractions
identified based on immunoreactivity in Western blot analysis with Golgi (anti-rab 6) or plasma membrane
(anti-ZO-3) specific marker proteins. All membrane fractions were assayed for fusion with ROS plasma
membrane vesicles. The plasma membrane enriched fractions (isolated at densities of 1·08 and 1·125 g
ml−1) containing tagged peripherin/rds and the Δ10 mutant promoted membrane fusion with ROS
plasma membrane vesicles. In contrast, fusion was not detected with plasma membrane vesicles from
mock-transfected cells or the Δ50 peripherin/rds deletion mutant. Fusion was enhanced in a less dense
fraction enriched in the P296T mutant (isolated from the 1·04/1·02 interface) relative to wt. Fusion was
dependent on the presence of peripherin/rds in the membranes and could be inhibited with trypsinolysis
and competition studies with the bovine fusion peptide, PP-5. Peptide competition suggests that the
fusion domain of human peripherin/rds is most likely identical to that characterized in bovine and
corresponds to amino acid residues 312–326. The C-terminal deletion mutants have allowed us to predict
the minimal region of the C-terminus necessary for fusion to include residues starting at number 335. In
addition a second region important in the formation of a fusion competent peripherin/rds has been
mapped to a region upstream of the fusion peptide domain.
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Peripherin/rds is proposed to function as a fusion protein within the rod outer segment and a
fusion domain has been mapped to amino acids 311–325 within the C-terminus. To map regions
within peripherin/rds required for membrane fusion a series of C-terminal mutants was analyzed.
Madin Darby canine kidney cells were transiently transfected with an Xpress or FLAG epitope
tagged peripherin/rds (wt) and three mutants of peripherin/rds. The mutants selected were a P296T
mutant (replacement of the proline at position 296 with a threonine) and two C-terminal deletion
mutants (one lacking the terminal 10 amino acids, Δ10 and one lacking the terminal 50 amino
acids, Δ50). The wt protein, the P296T and Δ10 mutants were detected on SDS–PAGE as 84 kDa
dimers, that resolved into 38–42 kDa monomers under reducing conditions. The Δ50 mutant
showed a slightly increased mobility. The cellular localization of mutants differed from that of wt
peripherin/rds. The wt Xpress-human and wt FLAG-bovine peripherin/rds were localized to both
intracellular and plasma membranes. In contrast, the C-terminal deletion mutants were localized
only to the intracellular membrane. The P296T mutant presented a still different pattern: initially
the protein localized to intracellular membranes. Upon confluence, however, the localization
appeared to become predominantly plasma membrane. To assess the fusion activity of the
proteins, the cell membranes were fractionated using sucrose density gradient centrifugation and
the various fractions identified based on immunoreactivity in Western blot analysis with Golgi
(anti-rab 6) or plasma membrane (anti-ZO-3) specific marker proteins. All membrane fractions
were assayed for fusion with ROS plasma membrane vesicles. The plasma membrane enriched
fractions (isolated at densities of 1·08 and 1·125 g ml−1) containing tagged peripherin/rds and the
Δ10 mutant promoted membrane fusion with ROS plasma membrane vesicles. In contrast, fusion
was not detected with plasma membrane vesicles from mock-transfected cells or the Δ50
peripherin/rds deletion mutant. Fusion was enhanced in a less dense fraction enriched in the
P296T mutant (isolated from the 1·04/1·02 interface) relative to wt. Fusion was dependent on the
presence of peripherin/rds in the membranes and could be inhibited with trypsinolysis and
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competition studies with the bovine fusion peptide, PP-5. Peptide competition suggests that the
fusion domain of human peripherin/rds is most likely identical to that characterized in bovine and
corresponds to amino acid residues 312–326. The C-terminal deletion mutants have allowed us to
predict the minimal region of the C-terminus necessary for fusion to include residues starting at
number 335. In addition a second region important in the formation of a fusion competent
peripherin/rds has been mapped to a region upstream of the fusion peptide domain.

Keywords
peripherin/rds; rod outer segment; membrane fusion; MDCK cells; photoreceptor; FLAGperipherin/rds; Xpress-peripherin/rds
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1. Introduction
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Photoreceptor rod cells are responsible for vision under dim light and mediate
phototransduction within specialized compartments termed rod outer segments (ROSs).
ROSs contain a densely packed stack of closed disk membranes (Roof and Heuser, 1982).
These post-mitotic cells maintain their structure and thereby their physiological function
through the co-ordinated processes of disk morphogenesis and disk shedding (Young, 1976).
New disks are formed at the base of the ROS, and older disks form disk packets at the apical
tip of the ROS, that are subsequently shed. The formation of new disks (Connell and
Molday, 1990; Travis, Sutcliffe and Bok, 1991; Goldberg, Moritz and Molday, 1995), and
the unusual flattened morphology of the disk rim require an integral membrane protein,
peripherin/rds (Wrigley et al., 2000). Interestingly, peripherin/rds has been proposed to play
a role in the membrane fusion processes that appear to be necessary in ROS renewal through
morphogenesis and shedding (Boesze-Battaglia et al., 1997, 1998).

Author Manuscript

The first indication that peripherin, the product of the RDS gene (Connell et al., 1991), was
essential for normal photoreceptor development came from the transgenic rescue of rds/rds
mice with copies of normal peripherin/rds (Travis, Sutcliffe and Bok, 1991; Travis et al.,
1992). In the rds mouse, a 10 kb insertion of exogenous DNA in the open reading frame of
peripherin/rds (Ma et al., 1995) resulted in the deletion of the entire C-terminus (Travis et
al., 1989). The disease process in rds/rds homozygotes and rds/+ heterozygotes is
characterized by abnormal development of photoreceptors, with the subsequent degeneration
of these cells leading to blindness (van Nie, Ivanyi and Demant, 1978; Jansen and Sanyal,
1984; Usukura and Bok, 1987). In heterozygotes, the ROSs are reduced in length, and
irregularly arranged with abnormal disk shedding (Sanyal, De Ruiter and Hawkins, 1980;
Cohen, 1983; Hawkins, Jansen and Sanyal, 1985). In the absence of the retinal pigment
epithelium (RPE) in a xenopus culture system, Jablonski, Wohabrebbi and Ervin (1999)
have observed the presence of whorl-like disorganized outer segments. In these disorganized
retinas the expression of opsin appears to be normal however, peripherin/rds expression is
up-regulated (Jablonski et al., 1999).
Peripherin/rds plays an essential role in the maintenance of the structure and stability of disk
membranes (Goldberg et al., 1995; Goldberg and Molday, 1996a,b). This four pass
transmembrane protein is localized to the rim region of photoreceptor cone and rod disk
Exp Eye Res. Author manuscript; available in PMC 2016 February 09.
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membranes (Arikawa et al., 1992), where it forms disulfide-linked homodimers (Goldberg et
al., 1995; Goldberg and Molday, 1996b) through an essential cysteine at position 150
(Goldberg, Loewen and Molday, 1998). Peripherin/rds homodimers complex non-covalently
(Loewen and Molday, 2000) with a non-glycosylated homologue, rom-1 (Bascom et al.,
1992) to form a heterotetrameric complex (Moritz and Molday, 1996; Goldberg and
Molday, 1996b). Detailed sedimentation velocity analysis of the oligomeric complexes
formed showed that peripherin/rds forms both homotetramers and peripherin/rds-rom-1
heterotetramers (Loewen and Molday, 2000). These studies also indicated that
peripherin/rds is present in a two-fold excess over rom-1 (Kedzierski, Weng and Travis,
1999a; Loewen and Molday, 2000). The formation of stable disulfide linked oligomers is
necessary in disk morphogenesis, through the formation of a disk rim and contributes to disk
membrane stability (Molday, 1994; Loewen and Molday, 2000). The inability to form such
complexes, through defects in either protein folding or subunit assembly, has been
demonstrated in disease-linked peripherin/rds mutants (Goldberg et al., 1995; Goldberg and
Molday, 1996b) and in digenic peripherin/rds-rom-1 mutants (Goldberg and Molday, 1996a;
Loewen, Moritz and Molday, 2001).
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A novel function for peripherin/rds, namely that of a membrane fusion protein, has been
identified. Purified peripherin/rds promotes membrane fusion between disk rims and ROS
plasma membrane in a cell-free assay system (Boesze-Battaglia et al., 1997). Fusion is
mediated through at least one region of the C-terminal domain from residues 311–325
(Boesze-Battaglia et al., 1998). A peptide analogue to this region, called PP-5, promotes two
necessary steps in the fusion process, membrane adhesion (Boesze-Battaglia et al., 1998)
and membrane destabilization (Boesze-Battaglia et al., 2000). This peptide is an amphiphilic
α-helix based on Fourier transform infrared spectroscopy (FTIR) (Boesze-Battaglia et al.,
1998), and this amphiphilic α-helical structure is necessary for the formation of a fusogenic
PP-5 oligomer (Boesze-Battaglia et al., 2000).

Author Manuscript

Peripherin/rds shares structural and functional homology with a growing family of
membrane fusion proteins (White, 1992; Pecheur et al., 1999). These proteins all contain a
fusion peptide domain that causes destabilization of the target membrane in the formation of
a fusion pore (for review, see Pecheur et al., 1999). Within the past decade many of these
proteins have been shown to have domains in close proximity to the fusion peptide domain,
that aid in providing for a fusion competent form of the protein (for review, see Mellman,
1995; Pecheur et al., 1999). In pH independent fusion processes, similar to those observed in
the ROS, these augmenter regions are involved in a number of fusion steps including: (1)
oligomerization of the fusion protein (Lawless et al., 1996); (2) binding of a fusion protein
to the receptor (Rabenstein and Shin, 1995); and/or (3) formation of a ‘hairpin’, necessary to
promote fusion pores (Weber et al., 1998; Wasserman, 1999). These processes lead to
conformational changes bringing the fusion peptide region into close proximity to the target
membrane. In vivo studies with peripherin/rds-rom-1 chimeric proteins support the
hypothesis that regions in addition to the highly conserved D-2 loop are also necessary for
normal ROS disk formation and proper peripherin/rds function (Kedzierski, Bok and Travis,
1999a). In vitro evidence also suggests that additional regions of the C-terminus of
peripherin/rds are important for fusogenic function (Muller-Weeks, Boesze-Battaglia and
Fitzgerald, 2001).
Exp Eye Res. Author manuscript; available in PMC 2016 February 09.
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The aim of the present study is to map regions within peripherin/rds required for membrane
fusion through a series of C-terminal peripherin/rds mutants that have been transfected into
Madin Darby canine kidney (MDCK) cells. The selection of MDCK cells rather than the
more commonly used COS cells (Goldberg et al., 1995, 1998; Goldberg and Molday,
1996a,b; Loewen and Molday, 2000; Loewen et al., 2001) was made based on preliminary
reports by Kim et al. (1998), who showed that peripherin/rds appeared to be localized to the
plasma membranes of these cells. In contrast peripherin/rds in COS cell expression systems
is where peripherin/rds is localized to the perinuclear membranes (Goldberg et al., 1995).
The localization of a peripherin/rds to the plasma membrane aids in confirming the
specificity of peripherin/rds mediated fusion events, independent of intracellular fusion
proteins. Wt bovine or human peripherin/rds were each expressed with an N-terminal
epitope tag, and thereby allowed us to detect and characterize a series of C-terminal mutants.
The results presented herein characterize two C-terminal deletion mutants, corresponding to
a 10 amino acid and a 50 amino acid deletion within the C-terminus. The development of an
N-terminal epitope tagged heterologously expressed protein provides a valuable tool in
mapping regions of the C-terminal domain involved in targeting peripherin/rds to the ROS
(Tam et al., 2001) and in promoting membrane fusion processes within the ROS.

2. Materials and Methods
Preparation of Human Peripherin/rds cDNA Expression Constructs and P296T Mutant

Author Manuscript
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Human poly A+ retina RNA (Clontech, Palo Alto, CA, U.S.A.) was reverse transcribed into
cDNA using an oligo-dT primer (Stratascript, Stratagene, La Jolla, CA, U.S.A.). The human
peripherin/rds was amplified by the polymerase chain reaction (PCR) using cloned Pfu DNA
polymerase (Stratagene, La Jolla, CA, U.S.A.). Oligonucleotide PCR primers were designed
to introduce Not1 restriction sites immediately upstream of the initiator methionine codon
and downstream of the stop codon of the human sequence (Travis et al., 1991). The sense
primer utilized was 5′-TAGCGGCCGCATGGCGCTACTGAAAGTCAAG and the antisense primer used was 5′-TAGCGGCCGCTCAGCCAGCCTCTGGGGCCT. PCR was
performed as described (Stratagene, La Jolla, CA, U.S.A.). Following denaturation at 94°C,
amplification consisted of 30 cycles of 1 min at 94°C + 1 min at 54°C + 1 min at 72°C. The
resultant peripherin/rds cDNA was blunt end ligated into the Bluescript II SK(+0)
(Stratagene, La Jolla, CA, U.S.A.) vector using T4 ligase and subsequently cloned into
XL-1Blue cells. Both strands were sequenced to exclude any PCR induced mutations. A
Not1 restriction fragment was then subcloned into the vector pCDNA3.1/His B (Invitrogen,
Carlsbad, CA, U.S.A.) to introduce epitope tag sequences to the N-terminus of the cDNA
and places it under the control of a constitutive cytomegalovirus promoter. A similar
construct, pCDNA3.1/His/lacZ, expressing B-galactosidase with an N-terminal Xpressepitope tag was used as a control (Invitrogen, Carlsbad, CA, U.S.A.).
The human peripherin/rds Not1 restriction fragment was subcloned into pGEMEX-2
(Promega) for subsequent mutagenesis using the GeneEditor in vitro Site Directed
Mutagenesis System (Promega) and transformed in the Escherichia coli strain JM109
(Promega). Orientation of the Not1 peripherin/rds cDNA fragment was determined by
restriction mapping. Mutations were oligonucleotide directed using custom primers obtained
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from Integrated DNA Technologies, Inc. The mutagenic primer with the sequence 5′GAGATTCCTCGGTGTTGGACACC-3′ was used to generate a substitution of proline at
position 296 to threonine. The mutation was verified by sequence analysis and subcloned by
Not1 restriction into the mammalian expressionvector pcDNA 3.1 His B.

Author Manuscript

Xpress-tagged peripherin/rds was purified using a Ni 2+ column. Briefly, 5 × 107 cells
expressing either wt or the P296T mutant were harvested in PBS, pelleted and resuspended
in native binding buffer consisting of 20 mM Na phosphate, 500 mM NaCl, and 30 mM
octylglucoside, pH 7·4. The cell lysates were sonicated 3× for 10 sec each and Poly-Histagged protein purified using the Xpress purification system under native conditions
(protocol as provided by Invitrogen, Carlsbad, CA, U.S.A.). The protein was eluted from the
column with increasing concentrations of imidazole (50, 200, 350 and 500 mM). The eluted
fractions were concentrated using Centricon 30 concentrators to 1 ml. Typically the yield of
Xpress-peripherin/rds from 5 × 107 cells was between 0·4 and 1·0 mg. The purity of the
protein was confirmed by SDS–PAGE and Western blot analysis using the anti-Xpress
antibody.
Preparation of Bovine Peripherin/rds cDNA Expression Constructs and C-terminal
Deletions of Peripherin/rds

Author Manuscript

Isolation and cloning of wild type and FLAG tagged peripherin/rds were obtained by PCR
using wild type bovine peripherin/rds as the template. Peripherin/rds PCR primers were
generated using the sequence published by Connell and Molday (1990). The PCR reactions
were performed as per the GIBCO/BRL Hot Start PCR protocol (Gibco/BRL, Rockville,
MD, U.S.A.). The optimum annealing temperature, 63°C for both reactions, was determined
using Oligo 6.3 software. The resulting PCR products, 1.·2 kb FLAG-peripherin/rds, were
purified, kinased and end filled by standard procedures (Sambrook, Fisher and Anderson,
1989). The FLAG-peripherin/rds cDNA were ligated into the SmaI cut mammalian
expression vector pCI-Neo (Promega, Madison, WI, U.S.A.) and verified by DNA
sequencing. To generate the C-terminal deletions, two 3′ peripherin/rds synthetic primers
were generated that correspond to progressive deletions of the C terminus. Each primer was
used in conjunction with the FLAG tagged peripherin/rds 5′ primer to amplify the specific
DNA fragments. The optimum annealing temperature for each reaction was 60°C. Each
FLAG-peripherin/rds deletion cDNA was purified and blunt end ligated into the pCI-Neo
mammalian expression vector (Promega, Madison, WI, U.S.A.) by standard methods
(Sambrook, et al., 1989). After transformation into DH5α E. coli, individual colonies were
selected and grown for DNA isolation. One wt FLAG-peripherin/rds, one Δ10 mutant and
one Δ50 mutant clone were chosen and confirmed by sequence analysis.
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Cell Culture and Transfections
MDCK strain II cells (Weimbs et al., 1997) were maintained in Eagle's minimal essential
growth medium (MEM) with Eagle's salts and L-glutamine (Mediatech, Herndon, VA,
U.S.A.), 10 % fetal bovine serum (FBS, Hyclone, Logan, UT, U.S.A.), 100 U ml−1
penicillin and 100 μg ml−1 streptomycin at 37°C in 5 % CO2 and 95 % air. The MDCK cells
were transfected using calcium phosphate precipitation (Breitfeld et al., 1989). Briefly, 10
cm plates with MDCK cells in log-phase growth were trypsinized and transfected in
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suspension with 20 μg of CaCl2 precipitated DNA. Cells were subsequently grown in
growth media for 3 days and passed into the selection medium, consisting of growth
medium in which G418 (Gibco BRL, Grand Island, NY, U.S.A.) 450 μg ml−1 was
substituted for penicillin and streptomycin. Ten to 14 days following selection, clones were
isolated using clone rings. Aliquots of stably transfected positive clones were banked and
thawed as needed for the experiments described below. The cell lines were passed weekly
with MEM containing 10 % FBS and 10 % penicillin/streptomycin solution and selected
using G418 (Wong, Low and Hong, 1992). Transient transfections were performed using
Lipofectamine PLUS reagent (Gibco BRL, Grand Island, NY, U.S.A.). The day before
transfection, cells were seeded according to the size of the culture vessel used, 1 × 106 cells
well in a six well plate or 3 × 106 cells per 15 cm dish. The amount of plasmid DNA was
likewise based on culture vessel size, 1 μg per well, or 2 μg per 15 cm dish. The
transfections were incubated for 3 hr at 37°C. Subsequently, the transfection media were
replaced with complete culture media and cells harvested within 48–72 hr.
Immunofluorescence and Laser Scanning Confocal Microscopy

Author Manuscript

For immunohistochemistry. MDCK cells were grown for 4–5 days on sterilized glass
coverslips in 100 × 200 mm dishes, supplemented with MEM with 10 % FBS and fixed in
1:1 methanol/acetone solution for 2 min. Alternatively, the cells were washed in PBS
containing 2 mM MgCl and 0·2 mM CaCl (PBS-C/M) and fixed in 2 % paraformaldehyde for
30 min at 4°C. The paraformaldehyde fixed cells were rinsed in PBS-C/M, quenched with
50 mM glycine for 10 min at 4°C and rinsed in PBS-C/M. Sequential incubations of primary
and secondary antibodies were performed for 1 hr each. The primary antibodies included
monoclonal anti-Xpress (Invitrogen, Calsbad, CA, U.S.A.), used at 1:2500 dilution,
monoclonal anti-FLAG-M5 antibody (10 μg ml−1) (Sigma, St. Louis, MO, U.S.A.). The
secondary antibodies utilized included goat anti-rabbit IgG FITC (Gibco BRL, Grand Island,
NY, U.S.A.), goat anti-mouse IgG FITC 594 (Gibco-BRL, Grand Island, NY, U.S.A.), goat
anti-mouse IgG Alex Fluor 594 (Molecular Probes, Eugene, OR, U.S.A.) and goat antirabbit IgG Alexa Fluor 488 (Molecular Probes, Eugene, OR, U.S.A.). For surface
immunofluorescence staining, coverslips were washed in PBS-C/M and incubated with
primary antibody for 1 hr at 4°C, prior to fixation with 2 % paraformaldehyde and
incubation with the seconday antibodies. Samples were analyzed on a Zeiss AXIOSKOP
fluorescent microscope capturing images at the magnifications indicated in the figures.
Scanning laser confocal microscopy was performed on a Zeiss AXIOVERT 100TV LSM.
Subcellular Fractionation of Membranes from Peripherin/rds Transfected and Control
MDCK Cells

Author Manuscript

Transfected MDCK cells were harvested upon confluency. The cells were scraped in
homogenizing buffer (0·1 M sodium phosphate, 1 mM DTT, 1 μg ml−1 leupeptin and 2 μg
ml−1 aprotinin) and collected by centrifugation (1000 g for 5 min). The resulting pellet was
resuspended in homogenizing buffer and the cells lysed by passage through a 26 gauge
needle (2×) and sonication (twice for 10 sec each). The membranes were fractionated on a
discontinuous sucrose density gradient as described (Oprian, 1993). The gradient was
prepared in a total volume of 8 ml, with four layers of each 2·0 ml of 5, 10, 20 and 30 %
w/w sucrose in homogenizing buffer. The gradients were centrifuged at 21·1 K for 25 min in
Exp Eye Res. Author manuscript; available in PMC 2016 February 09.
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a SW-41 rotor at 4°C. Fractions corresponding to the 1·04, 1·08 and 1·125 g ml−1 interfaces
and the pellet were collected, washed in homogenization buffer and collected by
centrifugation in a Ti-70 rotor, at 60 K for 25 min at 4°C. The resulting pellets were
resuspended in 50 mM Hepes, pH 7·4. The total protein content (Bio-Rad) and phosphate
content (Bartlett, 1959) of each individual fraction were determined.
Equal amounts of total protein from the fractionated membranes were separated using SDS–
PAGE (either 7·5 or 10 % acrylamide, as described in the figure legends), transferred to
nitrocellulose and Western blotting performed using anti-Xpress (Invitrogen, Carlsbad, CA,
U.S.A.), or anti-Rab-6 (CalBiochem; La Jolla, CA, U.S.A.); or anti-ZO-3 (Chemicon,
Temecula, CA, U.S.A.). In the case of anti-ZO-3 and anti-Rab 6 the secondary antibody
used was goat anti-rabbit IgG HRP (Life-Technologies, Grand Island, NY, U.S.A.).
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Preparation of Xpress-Peripherin/rds Large Unilamellar Vesicle (LUV) Recombinants
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Vesicles composed of phosphatidylcholine:phosphatidylserine:cholesterol (4:4:1 mole ratio)
and 1 mol % F18 were prepared as described previously (Boesze-Battaglia et al., 2000).
Briefly, the lipids were co-solubilized in chloroform, dried under N2, lyophilized and
resuspended in 10 mM Hepes, pH 7·4. The lipid suspension was sonicated 3 × for 3 min each
using a probe sonicator to form small unilamellar vesicles. The vesicles were combined with
purified Xpress-peripherin/rds using detergent dialysis as described previously for the
preparation of native peripherin/rds recombinants (Boesze-Battaglia et al., 1997). The
recombined membranes were dialyzed for 72 hr against 10 mM Hepes, 100 mM NaCl to
remove all traces of detergent. The recombined membranes were separated from
unincorporated proteins and pure lipid vesicles on a 5–40 % w/w sucrose density gradient.
The Xpress-peripherin/rds LUV recombinants were isolated at 32–35 % w/w sucrose. These
recombinants were spun down at 60 000 K for 20 min and resuspended in 10 mM Hepes, pH
7·4, prior to fusion assays.
Immunoprecipitation and Western Blot Analysis

Author Manuscript

Immunoprecipitation studies were performed as described (Springer, 1996). Briefly, cell
extracts prepared in NP-40 extraction buffer (50 mM Tris–HCl, pH 7·4, 250 mM NaCl, 0.1 %
NP-40, 5 mM EDTA, 50 mM NaF) were incubated on ice for 20 min, sonicated (twice for 10
sec each) and centrifuged at 14 000 rpm for 10 min. Anti-Xpress monoclonal antibody was
added to each of the cell extracts and incubated overnight while rotating at 4°C. Following
immunoprecipitation with 150 μl of Protein A sepharose the complexes were washed five
times in NP-40 buffer and resuspended in 2× SDS–PAGE sample buffer containing βmercaptoethanol (β-ME). After heating at 85°C for 10 min the complexes were centrifuged
at 14 000 rpm for 30 sec and the immunoprecipitated complexes separated on SDS–PAGE
and transferred to nitrocellulose for Western blot analysis (Boesze-Battaglia et al., 1997) or
silver stained (Merrill, Goldman and Van Keuran, 1982). In some experiments, the
immunoprecipitated products were subsequently treated with Endoglycosidase H (ENDO-H,
Connell and Molday, 1990) prior to electrophoresis. The immunoreactive bands were
visualized using the ECL detection system (Pierce) and molecular weights calculated using
Rf measurements of molecular weight makers.
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Fusion between the R18 labeled ROS plasma membranes (R18-ROSPM) and the MDCK cell
lysates and membranes fractioned as described above was measured essentially as described
for disk membranes and peripherin/rds recombinants (Boesze-Battaglia, 2000). Bovine ROS
plasma membrane vesicles were isolated (Boesze-Battaglia and Albert, 1989) and labeled
with octadecylrhodamine B-chloride (R18) (Boesze-Battaglia, Albert and Yeagle, 1992). The
purity of the plasma membrane fraction was determined by the cholesterol to phospholipid
ratio (0·35) and confirmed by Western blot analysis of disk and plasma membrane fractions
probed with anti-63 kDa cGMP channel monoclonal antibody, PMc 1D1 (a gift from Dr Om
Lamba) and mAb 2B6 to bovine peripherin/rds (a generous gift from Dr R. Molday). The
ROS plasma membrane was found to be immunoreactive with the channel antibody PMc
1D1, and not immunoreactive with monoclonal antibody 2B6 (data not shown). The labeled
vesicles were stored on ice for 1–2 hr or used immediately.
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Upon fusion, the R18 probe is diluted throughout the target membrane by lateral diffusion
leading to a dequenching and an increase in the observed fluorescence intensity that is
proportional to membrane fusion (Hoekstra, et al., 1984). Fusion was initiated with the
addition of R18 labeled plasma membrane (R18-ROSPM) to target membranes at 37°C. All
target membranes were 1 mM total phospholipid based on phosphate analysis (Bartlett,
1959). In some cases the target membranes were pretreated with various peptides for 30 min
in the dark or treated with trypsin as described (Boesze-Battaglia et al., 1998). Fluorescence
was monitored with λex = 560 nm and λem = 586 nm using a Perkin-Elmer LS 50B spectrofluorometer. The fluorescence intensity in the absence of R18-ROSPM was taken as
baseline. The fluorescence at infinite probe dilution (100 % fluorescence) was determined
with the addition of 100 μl of 10 % Triton X-100. Initial rates of fusion were determined
from the increase in fluorescence intensity as a function of time.
Resonance Energy Transfer (RET) Fusion Assay
The fusion between R18 labeled plasma membranes and F18 labeled membranes was
measured using a fluorescence resonance energy transfer (RET) assay (Partearroyo et al.,
1994) at room temperature on a Perkin-Elmer LS 50B spectrofluorometer (Gaithersburg,
MD, U.S.A.) equipped with a 96 well plate reader. Fusion was initiated with addition of R18
labeled plasma membranes to F18 labeled membranes already present in the well.
Fluorescence intensity was measured at λex = 460 nm (F18 excitation) and at λem = 524 nm
(F18 emission) and λem = 592 nm (R18 emission) over a 2 min period. The extent of fusion
was calculated as the change in R18 intensity over time as described (Partearroyo et al.,
1994). The change in R18 intensity (ΔR) at a given time was computed as follows:

Author Manuscript

I524 and I592 are the fluorescence intensities at 524 and 592 nm, respectively. The subscripts
T and I represent a given time point and the initial time point of each sample, respectively.
The percentage change in R18, indicated in the graphs as the percent fusion, was determined
my multiplying each ΔR value by 100. Background percentage change in R18 was calculated
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for the mock-transfected cells and subtracted from the peripherin/rds MDCK cell membrane
results, the background values accounted for less than 2 % of the total change in R18
fluorescence. In some studies the target membranes were pretreated with peptides for 30 min
at 37°C as indicated in the legends to the figures. The amino acid sequences of the peptides
used were; NP-1; H2N–ALLKVKFDQKKRVKLAQ–COOH and PP-5; H2N–
VPETWKAFLESVKKL–COOH. In the resonance energy transfer assays, 10 μg of PP-5
was added to the F18 labeled target membrane samples prior to the addition of R18 labeled
ROS plasma membrane.

3. Results
Heterologous Expression of Xpress-human Peripherin/rds and FLAG-bovine
Peripherin/rds wt and Mutants in MDCK Cells

Author Manuscript
Author Manuscript

To map regions within the C-terminus of peripherin/rds that contribute to membrane fusion,
two C-terminal deletion mutants and a single amino acid substitution at position 296
(position based on human sequence, Dryja et al., 1997) were studied. To facilitate detection
of the wt and mutant proteins, the bovine peripherin/rds was engineered with an N-terminal
FLAG epitope tag and the human peripherin/rds with an N-terminal Xpress tag. The C
terminus of peripherin/rds is a 64 amino acid extradiskal domain that spans amino acid
residues 282–345. A Chou–Fasman helix analysis of this region predicts three α-helical
regions that are labeled 1, 2 and 3 in Fig. 1. The Δ10 mutant removes residues 345–335,
thereby truncating the first α-helical domain. The Δ50 mutant removes residues 345–295,
removing the fusion peptide domain and essentially the entire C terminus. The single amino
acid substitution replaces proline at position 296 with threonine (P296T) in a highly
conserved region of the C terminus (Kedzierski et al., 1996) postulated to be involved in
fusion due to its homology with other membrane fusion proteins (Mellman, 1995; Gerst,
1999; Pecheur et al., 1999).

Author Manuscript

Wild type human Xpress-peripherin/rds, the P296T mutant, the full-length bovine FLAGperipherin/rds and C-terminal deletion constructs were each individually transiently
transfected into MDCK cells. Protein expression was confirmed by Western blot analysis of
cell lysates. In addition to the transient transfections, an N-terminal Xpress-epitope tagged
human peripherin/rds was stably transfected into MDCK cells in three distinct cell lines
designated 13, 22 and 38. The level of Xpress-peripherin/rds expression was highest in cell
line 22 and the characterization of Xpressperipherin/rds in this cell line is discussed. The
other two cell lines showed qualitatively similar results (data not shown). WT Xpressperipherin/rds expression in MDCK line 22 [Fig. 2(B), lanes 7 and 8] and in transiently
transfected MDCK cells [Fig. 2(B), lanes 1 and 2] was compared to mock-transfected
MDCK cells [Fig. 2(B), lanes 3 and 4] transiently transfected COS cells [Fig. 2(B), lanes 5
and 6; Goldberg, et al., 1995], and native bovine peripherin/rds in ROS disk membranes
[Fig. 2(A), lane 1] by Western blot analysis. The native disk membrane peripherin/rds was
detected with monoclonal antibody 2B6 and shown to be a 34–38 kDa monomer under
reducing conditions [Fig. 2(A), lane 1]. The heterologously expressed human protein was
detected using anti-Xpress (monoclonal) antibody [Fig. 2, lanes 1 and 2, transiently
transfected; lanes 7 and 8 stably transfected]. Both the Xpress-tagged human peripherin/rds
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and the FLAG tagged bovine peripherin/rds (data not shown) banded at 82 kDa indicative of
a dimer that was resolved into a single 42 kDa band in the presence of BME, consistent with
in vivo disulfide homodimer formation. The slightly higher molecular weights of the Xpress
and FLAG tagged proteins are due to the presence of the epitope tag on the peripherin/rds in
the MDCK cell transfections. The Xpress-P296T peripherin/rds mutant was also detected as
a dimer that resolved into a 38 kDa monomer in the presence of BME [Fig. 2(C), lanes 1 and
2]. The wt and P296T Xpress-peripherin/rds proteins were subsequently purified using from
a Ni2+ column and fractions eluted with 200 mM imidizole found to contain the
Xpressperipherin/rds. These proteins were detected as 42 kDa monomers under reducing
conditions [Fig. 2(D), lanes 1 and 2].
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Peripherin/rds isolated from bovine ROSs, and as a heterologously expressed protein in COS
cells (Goldberg et al., 1995) is glycosylated and glycosidase treatment produces a core
polypeptide (Travis et al., 1991; Goldberg et al., 1995). The post nuclear lysates from the
transfected MDCK cells were analyzed for Endogylcosidase H (Endo-H) sensitivity. As
seen in Fig. 3, there is an increase in the mobility of Endo-H treated peripherin/rds
suggesting a high mannose or hybrid carbohydrate modification of the protein (Travis et al.,
1991). The molecular weight of the core polypeptide was 34 kDa, in close agreement with
that observed in vivo and in transgenic animals with a S231A mutation (Kedzierski et al.,
1999b). A portion of the FLAG tagged peripherin/rds and the two C-terminal deletion
mutants were sensitive to Endo-H as shown in Fig. 3(A). The Xpress-P296T mutant was
also found to be Endo-H sensitive as shown in Fig. 3(B). Residual amounts of Endo-H
resistant proteins were found to be variable with transfections, however they were higher
with the FLAG tagged peripherin/rds than the Xpress-tagged proteins. Collectively, these
results suggest that the expressed peripherin/rds forms disulfide linked dimers, and is
glycosylated suggesting that it is not grossly misfolded. The properties shown here are
similar to those observed in vivo (Connell and Molday, 1990; Travis et al., 1991) and in
other cell expression systems (Goldberg et al., 1995).
Immunolocalization of Xpress-human Peripherin/rds and FLAG-bovine Peripherin/rds wt
and Mutants in MDCK Cells

Author Manuscript

Protein expression of human peripherin/rds was confirmed in MDCK cells and localization
was accessed microscopically using a fluorescently labeled secondary antibody to the
monoclonal anti-Xpress antibody [Fig. 4(A) and (B)], and to a polyclonal antibody to
peripherin/rds [Fig. 4(C)]. This polyclonal antibody was generated against a peptide to the
C-terminal domain of peripherin/rds (Covance Inc.). In transfected MDCK cells, labeling
appears to be localized to both the intracellular membranes and to the plasma membrane
surface based on labeling with either anti-Xpress or the polyclonal antibody [Fig. 4(A) and
(C)]. When these same cells were fixed in paraformaldehyde, and labeled with anti-Xpress,
labeling also appeared to be plasma membrane associated [Fig. 4(B)]. In a complementary
experiment, pretreatment of the transfected MDCK cells with trypsin, prior to fixation,
decreased plasma membrane associated immunofluorescence [inset, Fig. 4(C)] as detected
by a peripherin/rds polyclonal antibody. Qualitatively similar results were observed with
anti-Xpress (data not shown). In contrast, mock-transfected MDCK cells do not show
appreciable immunoreactivity with either the polyclonal antibody [Fig. 4(D)] or anti-Xpress
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[Fig. 6(D)] or anti-FLAG [Fig. 5(A), inset]. Collectively, the paraformaldehyde fixation and
pretreatment of cells with trypsin suggest that a portion of the peripherin/rds is localized to
the plasma membrane, a conclusion suggested first by Kim et al., (1998).
Immunofluorescent localization of the Δ10 and Δ50 mutant shows a different pattern, with
very little to no immunoreactivity at the plasma membrane when cells were fixed with
MeOH/acetone or 2 % paraformalde-hyde [Fig. 5(B), (C) and (D)]. These deletion mutants
appear to be localized almost exclusively intracellularly.
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The immunofluorescent localization of Xpress wt peripherin/rds and the P296T mutant was
accessed in more detail using laser confocal microscopy. The P296T mutant exhibited a very
interesting localization pattern [Fig. 6(A) and (B)]. In single non-confluent cells, the labeling
appeared to be localized exclusively to intracellular vesicles [Fig. 6(A), inset]. Upon
confluence the label was further distributed to the plasma membrane, specifically to areas
that appear to be tight junctions [Fig. 6(A), see arrow]. A similar localization pattern was
also observed when the P296T expressing cells were fixed in 2 % paraformaldehyde [Fig.
6(B)]. As shown in Fig. 6(C), using a fluorescently labeled secondary antibody to the
monoclonal anti-Xpress antibody, wt protein is expressed in the intracellular membranes
with some signal seen in the plasma membrane.
Fractionation of MDCK Cell Membranes Expressing Peripherin/rds
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The immunofluorescent localization studies presented in Figs 4 and 6 suggest that a portion
of both wt Xpress-human peripherin/rds localizes to the plasma membrane. To corroborate
the localization of the expressed proteins biochemically, membranes isolated from the
transfected MDCK cells were fractionated using sucrose density gradient centrifugation.
Four fractions were isolated at the 1·02/1·04 g ml−1 interface, 1·04/1·08 g ml−1 interface,
1·08/1·125 g ml−1 interface and are designated fraction 1, 2, 3 and pellet, respectively. Using
an antibody to a plasma membrane specific protein, ZO-3, and an antibody to a Golgi
specific protein, rab-6, the predominant membrane species in each of the four fractions were
identified based on Western blot analysis. As shown in Fig. 7, all four fractions were
immunoreactive to anti-ZO-3 antibody. Only two of these fractions, fraction 1 and the pellet
contained detectable levels of intracellular membrane based on immunoreactivity with rab-6.
In contrast, fractions 2 and 3 contained no detectable levels of Golgi membranes, based on
the absence of immunoreactivity with anti-rab 6 antibody, suggesting that these two
fractions were the most highly enriched in plasma membrane relative to intracellular
membrane fragments. All four membrane fractions contained wt Xpress-peripherin/rds
detected by Western blot analysis (Fig. 7). Similar results were obtained with the wt FLAGbovine peripherin/rds (data not shown). The detection of Xpress-peripherin/rds in fractions
enriched in plasma membrane (fractions 2 and 3) is consistent with the immunofluorescence
microscopy (Figs 4 and 6), which suggests that a portion of the Xpress-tagged peripherin/rds
has localized to the MDCK cell plasma membrane.
Membrane Fusion Studies
To establish the fusion competency of the expressed wt peripherin/rds, fusion between the
wt peripherin/ rds containing membrane fractions and bovine ROS plasma membrane was
determined using fluorescence dequenching. This assay was chosen to allow a direct
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comparison of the fusion kinetics and parameters of the expressed peripherin/rds to those
characterized previously in native disk membranes and purified peripherin/rds LUVs
(Boesze-Battaglia, et al., 1992, 1997, 1998). The mock-transfected and wt Xpressperipherin/rds MDCK cell membrane fractions, 1, 2, 3 and pellet, described in Fig. 8 were
isolated and used immediately for fusion assays. Upon the addition of R18 labeled ROS
plasma membrane vesicles, heretofore designated as R18-ROS PM, to MDCK cell plasma
membrane enriched fraction 2, an increase in fluorescence intensity at 586 nm indicative of
fusion was observed (data not shown). From this increase in fluorescence intensity the initial
rate of fusion (IRF) was calculated as described (Boesze-Battaglia et al., 1992) and is shown
in Table I. Fraction 3 showed qualitatively similar results, although the initial rate of fusion
in those experiments was somewhat lower (Table I). In contrast to fractions 2 and 3, the
pellet and fraction 1 from the transfected cells showed no detectable fusion with R18-ROS
PM as shown in Table I. Little detectable fusion was observed between mock-transfected
MDCK cell membrane fractions (1–3) and R18-ROS PM (Table I). Quantitatively similar
results were obtained with the FLAG-peripherin/rds (data not shown).
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Peripherin/rds promoted fusion is mediated by a 14 amino acid long C-terminal region of the
protein that is 100 % homologous to a corresponding region in human peripherin/rds (amino
acids 312–326). Trypsinolysis of peripherin/rds cleaves the entire C terminus, including the
fusion domain thereby resulting in a decrease in bovine peripherin/rds-dependent fusion
with R18-ROS PM (Boesze-Battaglia et al., 1998). The specificity of the fusion between
MDCK cell plasma membrane enriched fractions containing Xpress-peripherin/rds
(fractions 2 and 3) and R18-ROS PM was addressed by trypsinolysis. When R18-ROS PM
was added to trypsin treated Xpress-peripherin/rds membrane fractions 2 and 3, very little
change in R18 fluorescence intensity was observed (Table I). When the trypsin supernatant
of these cell fractions was assayed it was found to be immunoreactive with antiperipherin/rds monoclonal antibody 2B6, suggesting that the C-terminal domain of the
expressed peripherin/rds had been cleaved (data not shown). These results suggest that
trypsinolysis inhibits fusion most likely in a manner similar to that characterized in bovine,
by cleaving the fusion promoting region of the Xpress-peripherin/rds.
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To provide additional evidence for the specificity of fusion detected as that due to Xpressperipherin/rds, the authors exploited an observation made previously when studying fusion
between peripherin/rds LUVs and R18-ROS PM (Boesze-Battaglia et al., 1997, 1998). In
this system, addition of PP-5, a synthetic peptide analogue to the fusion domain, inhibited
peripherin/rds-dependent fusion. The addition of PP-5 to the Xpress-peripherin/rds MDCK
membrane fractions 2 and 3 prior to fusion with R18-ROS PM resulted in a decrease in the
initial rate of fusion (Table I). These results suggest that the fusogenic species in the MDCK
cell membrane fractions was peripherin/rds. In contrast, pretreatment of fractions 2 and 3
with a peptide to the N-terminal domain of peripherin/rds, called NP-1, had no effect on
fusion. Additionally when the membrane fractions from both peripherin/rds and mocktransfected MDCK cells, fractions 1, 2, 3 and pellet were incubated with R18 labeled disk
membranes or R18 labeled phosphatidylcholine vesicles, no increase in fluorescence
intensity was observed (data not shown), indicating that the fusion detected is specific to a
ROS plasma membrane, peripherin/rds mediated process. These results also confirm that no
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fusion independent transfer of R18 is contributing to the increase in fluorescence intensity
observed.
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To access the fusogenic function of the various peripherin/rds mutants an alternative
fluorescence based fusion assay was utilized. In these studies [Fig. 8(A)–(C)] fusion was
detected using fluorescence RET methods. This assay is advantageous with the mutants
because it requires equal amounts of target and donor membrane vesicles, in contrast to the
R18 lipid-mixing assay, which requires a 10-fold excess of target membrane. The RET assay
is preferred since the yield of MDCK cell membrane material is limited in the transiently
transfected cells. In the RET assays, upon fusion of an F18 labeled target membrane with
R18-ROS PM vesicles an increase in R18 fluorescence (λem = 592 nm) is observed due to a
transfer of energy from the F18 (λex = 470 nm) when it is in close proximity to the R18 (i.e.
upon fusion of the two membranes). Upon the addition of R18-ROS PM to F18 labeled
unfractionated MDCK cell membranes an increase in R18 fluorescence was observed with a
concomitant decrease in F18 fluorescence (data not shown). The time course of fusion
between ROS PM and cell membranes isolated from wt Xpress-human p/rds, Δ10, Δ50 and
the P296T mutant is shown in Fig. 8(A). Relative to the wt, a slight increase in fusion was
observed between the Δ10 mutant and R18-ROS PM at all time points. A much larger
enhancement of fusion was observed when fusion between the P296T mutant and R18-ROS
PM was compared to wt. The observed increase in fusion could be due to increased levels of
protein expression in the Δ10 and the P296T mutant. However, when levels of expressed
protein were compared, less protein was detected in the P296T mutant, suggesting that the
higher fusion rate was not attributable to the presence of more fusion protein [Fig. 8(B),
inset]. The fusion between R18-ROS PM and wt, P296T or the Δ10 mutants was inhibited
with the addition of PP-5 (data not shown), further suggesting that the fusion event
measured with the RET assay was specific for peripherin/rds.
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The fusion between R18-ROS PM and subcellular fractions isolated from the transiently
transfected MDCK cell lines was compared. The transiently transfected MDCK cells were
lysed and the membrane subpopulations separated on sucrose density gradients as described
above (Fig. 7). The percent fusion between R18-ROS PM and the various membrane
fractions is shown in Fig. 8(B) and the level of protein expression in each fraction is shown
in the inset. The wt and the Δ10 mutants both show maximal fusion activity in membranes
isolated in fraction 2, enriched in Z0-3, a plasma membrane specific marker. In contrast, the
P296T mutant has highest fusion activity in less dense membrane species, isolated at the
1·04/1·08 g ml−1 interface. This fraction is enriched in rab-6 suggesting that it is a
peripherin/rds bearing post-Golgi vesicle. The percentage fusion in this figure was
normalized to protein content. Since the argument can be made that there is substantially
more lipid surface area in the lighter fraction the phospholipid was compared to the protein
ratio of the various fractions. The phospholipid/protein ratios are similar, corresponding to
3·0, 2·04, 1·72 and 2·10 (mg/mg) for fractions 1–3 and pellet, respectively, further
suggesting that the enhanced fusion seen with the P296T mutant is most likely due to a
change in the C-terminal domain of this protein. In all of the fractionated membranes fusion
was completely inhibited upon trypsinolysis of the membranes and fusion between P296T
and R18-ROS PM and wt p/rds and R18-ROS PM could also be inhibited with the addition of
PP-5 (data not shown). To further support the conclusion that the P296T mutation results in
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an enhancement of peripherin/rds-dependent fusion, lipid recombinants containing either the
WT Xpressperipherin/rds or the P296T mutant were prepared and assayed for fusion. The
result of the RET fusion measurements between F18 labeled recombinants and R18-ROS PM
are shown in Table II. When compared to WT fusion is enhanced with the P296T mutant.
This enhancement is not due to variations in protein incorporation since both recombinants
had phospholipid protein ratios on the order of 90 mol phospholipid per mol protein.
Collectively, these results have allowed us to map additional regions within the C-terminus
specifically a region of as yet undefined length upstream of the fusion peptide domain
(residues 311–325), which contains proline 296.

4. Discussion
Author Manuscript
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The results herein report the development of a heterologous expression system (MDCK
cells) for the study of photoreceptor peripherin/rds. Both FLAG N-terminal epitope tagged
bovine peripherin/rds and Xpress-N-terminal epitope tagged human peripherin/rds were
expressed as disulfide linked oligomeric glycoproteins (Fig. 2), that were able to promote
membrane fusion with ROS PM vesicles (Table I). The biochemical properties of the
expressed proteins are similar to the native protein in ROS. The expressed wt and mutant
proteins all form dimers that are reduced to monomers in the presence of reducing agents as
observed in vivo (Connell and Molday, 1990; Travis et al., 1991) and in other heterologous
expression systems (Goldberg et al., 1995; Goldberg and Molday, 1996a,b). The expressed
proteins appear to be processed through the Golgi and are glycosylated as evidenced by
sensitivity to Endo-H. The level of Endo-H resistant protein appears to be higher in cells
expressing the FLAG tagged bovine construct when compared to the Xpress-tagged
constructs (Fig. 3). These resistant species may be due to incompletely processed or
misfolded proteins; incompletely processed species were also observed when bovine
peripherin/rds was expressed in COS cells (Goldberg et al., 1995). As observed previously,
glycosylation is not required for subunit assembly in vivo (Kedzierski et al., 1999b) and
does not alter the flattened shape of microsomal membranes in an in vitro cell free system
(Wrigley et al., 2000).
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Immunofluorescence microscopy data show localization of wt peripherin/rds to both
intracellular membranes and plasma membrane of MDCK cells. Peripherin/rds appears to be
properly folded in the plasma membrane fraction based on analysis of fusogenic function of
subcellular fractions. The localization of peripherin/rds in the MDCK cells is in contrast to
COS cells, in which peripherin/rds is localized exclusively to the perinuclear membrane
(Goldberg et al., 1995). In MDCK cells human peripherin/rds also sorts to the plasma
membrane. Moreover, this sorting does not require rom-1, the non-glycosylated homolog of
peripherin/rds in vivo. Rhodopsin has been expressed in MDCK cells and this protein
localizes to the apical membrane (Chuang and Sung, 1998). Kim et al. (1998) reported that
the Xpress-human peripherin/rds was localized to the MDCK cell basolateral membrane.
Collectively, the work presented herein and the characterization of rhodopsin expression in
MDCK cells suggests that the MDCK cell expression system may provide a tool used to
identify localization signals that direct these proteins to different membranes in rod cells.
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The localization pattern of the Xpress-P296T peripherin/rds mutant protein from
intracellular membranes to the plasma membrane upon confluence is somewhat unusual.
The confocal images shown in Fig. 6, suggest that the P296T mutant may become associated
with the tight junctions, suggesting that peripherin/rds may co-localize with other proteins
associated with this region. This possibility is presently under investigation. Interestingly,
glycoprotein B of cytomegalovirus, a functional homolog (i.e. fusion protein) of
peripherin/rds (Navaro et al., 1993), is endocytosed from the plasma membrane of MDCK
cells (Tugizov et al., 1999). The signal for endocytosis is a cluster of acidic amino acids
within the C-terminal domain. Similar staining patterns are observed as the glycoprotein B is
sorted within the MDCK cells. Whether peripherin/rds sorts by a similar mechanism remains
to be determined.
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Functionality of the expressed proteins was defined as the ability to promote fusion with
ROS PM vesicles. The Xpress-tagged human peripherin/rds and the FLAG tagged bovine
peripherin/rds were able to promote membrane fusion between ROS plasma membrane
vesicles and MDCK cell membrane fractions in a manner similar to native purified bovine
peripherin/rds. In both cases, fusion required nano-molar levels of calcium (Table I), was
inhibited upon trypsinolysis (Table I) and with the addition of PP-5 (Table I), a synthetic
peptide analogue to the fusion domain of bovine peripherin/rds. The specificity of the fusion
was inferred from competition studies using PP-5, which corresponds to amino acids 312–
326 of human peripherin/rds (Dryja et al., 1997). Within this region there is complete
conservation of amino acid between human and bovine peripherin/rds lending further
support for a common functional domain. The ability to promote fusion is most likely not
due to an artifact of misfolding since it has been previously shown that misfolded protein, as
determined by heat denturation, is unable to promote fusion (Boesze-Battaglia et al., 1997).
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Peripherin/rds shares structural and functional homology with an extensive and wellcharacterized group of membrane fusion proteins. In addition to a fusion peptide domain,
these membrane fusion proteins contain regions that are required not only for the formation
of a fusion pore but also to confer fusion competency to the protein and specificity to the
fusion process (Mellman, 1995; Skehel and Wiley, 1998). Recently, the fusion protein
fertilin has been shown to contain regions upstream of the fusion peptide domain, which
contribute to targeting and fusion pore formation (Pecheur et al., 1997, 1999). The HIV
fusion protein, gp41, also contains conserved amino acid residues essential for the formation
of an ectodomain in an area upstream of the fusion peptide and adjacent to the
transmembrane domain (Liu et al., 2001).
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To define broadly the regions of the C-terminus that contribute to the fusion process, a series
of six deletion mutants was constructed. Two of these deletions, a Δ10 and a Δ50 mutant are
described here and the other four deletion mutants (Δ20, Δ29, Δ39 and Δ59) are described
elsewhere (Muller-Weeks et al., unpublished res.). In these previous studies, all four deletion
mutants lost fusogenic function. The Δ20 mutant in those studies still retained the fusion
domain but removed the first predicted α-helix (based on Chou-Fasman analysis). It was
proposed that the inactivity of the Δ20 mutant was due to the inability of the fusion peptide
domain to maintain proper helical conformation. Herein it was found that the Δ10 mutant,
the shortest deletion still retained fusogenic function. It has been previously shown that
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addition of monoclonal antibody 2B6 (with epitope corresponding to amino acids 330–345)
to either disk membranes or peripherin/rds LUVs results in a partial inhibition of fusion.
Deletion of the entire 2B6 epitope (Δ20 mutant) resulted in no detectable fusion between
peripherin/rds and ROS PM vesicles (Muller-Weeks et al., unpublished res.). Collectively
these results suggest that a region from amino acids 325–335 may aid in promoting fusion.
While the experiments as designed did not address the lag-time associated with fusion,
slightly longer ‘lag-time’ was observed with the Δ10 mutant when compared with wt (data
not shown). Taken together these results suggest that the terminal 10 amino acids may be
necessary to render peripherin/rds fusion competent, as evidenced by a slight increase in lagtime associated with this mutant. As expected deletion of 50 amino acids resulted in no
detectable fusion.
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Phylogenetic homology has been observed in the peripherin/rds protein between residues
294–314, a region containing the fusion peptide domain (Kedzierski, et al., 1996). Using
well-characterized membrane fusion processes (i.e. fertilin, synaptobrevin and intracellular
fusion) as a paradigm, it was hypothesized that the region corresponding to amino acids
294–312 in bovine and human peripherin/rds may be necessary for membrane fusion. To
determine if this region of peripherin/rds is involved in the fusion process a threonine
residue was substituted for the proline residue at position 296. A higher initial rate of fusion
between membranes containing the P296T mutant and ROS PM was observed when
compared to wt Xpress-peripherin/rds (Fig. 8 and Table II). The P296T mutant is a nonconservative substitution, resulting in a change in this region of the protein from aliphatic to
a more polar, hydrophilic region. If peripherin/rds functions in a manner analogous to other
fusion proteins, it is likely that the fusion permissive form of this protein requires a coiledcoil structure (Bentz, 2000), which would require that a ‘hairpin’ form upstream of the
fusion peptide. In this case an increase in hydrophilicity as would occur with a substitution
of proline to threonine could alter the properties of the fusion protein. A similar mutation in
gp-41 has been shown to favor the hairpin structure of the protein and enhance fusion (Liu et
al., 2001).
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Collectively the results herein allow us to refine further our working hypothesis of
peripherin/rds mediated fusion. It is proposed that a region upstream of the fusion peptide
domain of peripherin/rds aids in rendering the protein fusion competent most likely by
aiding in a required change in conformation, possibly through the formation of a required
‘hairpin’. Disease-linked C-terminal mutations of peripherin/rds are assembled into two
small but distinct clusters, a group within the homologous region and a smaller group within
the fusion peptide domain (residues 311–325) (Kohl et al., 1998). The identification of three
genetic polymorphisms in this region may make it more difficult to screen for defects in this
area using conventional genetic approaches (Kohl et al., 1998). Such a cluster of mutations
is consistent with the high functional efficacy of these regions.
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Fig. 1.

Schematic representation of the peripherin/rds C terminus and mutants. The amino acid
sequence of bovine peripherin/rds is presented (residues 282–345). A Chou-Fasman analysis
of the C-terminus reveals three alpha-helical regions that are denoted as □ and numbered 1,
2 and 3. The fusion peptide domain is underlined and corresponds to helix 2. Two Cterminal deletion mutants were constructed as designated Δ10 (removal of residues 335–
345) and Δ50 (removal of residues 295–345). An arrow indicates deletion endpoints. A third
single amino acid substitution from proline to threonine at position 296 is indicated by an
arrow and is boxed.
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Western blot analysis of Xpress-human peripherin/rds in MDCK and COS-1 cells. (A)
Bovine ROS disk membrane proteins were separated by electrophoresis under reducing (+βME) denaturing conditions and then Western blotted with anti-peripherin/rds monoclonal
antibody 2B6. (B) Detergent extracts of MDCK cells transiently transfected with Xpresshuman peripherin/rds (lanes 1 and 2), mock transfected (vector alone, lanes 3 and 4), or
stably transfected (lanes 7 and 8) and detergent extract of COS-1 cells transiently transfected
with Xpress-peripherin/rds (lanes 5 and 6) were electrophoresed under reducing or nonreducing (±β-ME) denaturing conditions and then Western blotted with a monoclonal
antibody to the Xpressepitope tag on the human peripherin/rds. (C) Cell extracts of MDCK
cells transfected with the Xpress-P296T mutant human peripherin/rds was electrophoresed
under reducing or non-reducing (±β-ME) denaturing conditions and then Western blotted
with a monoclonal antibody to the Xpress-epitope tag on the human peripherin/rds. (D)
Fractions isolated from Ni2+ column with 200 mM imidazole corresponding to wt Xpressperipherin/rds (lane 1) and P296T Xpress-peripherin/rds (lane 2) were electrophoresed and
then Western blotted with a monoclonal antibody to the Xpress-epitope tag on the human
peripherin/rds.
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WT peripherin/rds and mutant proteins are deglycosylated by Endo-H. (A) Anti-FLAG-M5
monoclonal antibody immunoprecipitated complexes of MDCK cell extracts transfected
with FLAG-bovine peripherin/rds, designated WT, Δ10 mutant and Δ50 mutant treated with
ENDO-H (+) or untreated (−) were separated on 10 % SDS–polyacrylamide gels in the
presence of β-ME, transferred to nitrocellulose and probed with anti-FLAG antibody, M-5.
(B) MDCK cell extracts transfected with Xpress-human wt or P296T mutant peripherin/rds
treated with ENDO-H (+) or untreated (−) were separated on 10 % SDS–polyacrylamide
gels in the presence of β-ME, transferred to nitrocellulose and probed with anti-Xpress
antibody.
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Immunolocalization of human Xpress-peripherin/rds in transfected MDCK cells. MDCK
cells expressing wt Xpress-human peripherin/rds were grown on glass coverslips, fixed in
MeOH/acetone (A) or 2 % paraformaldehyde (B) and incubated with anti-Xpress antibody.
MDCK cells expressing wt Xpress-human peripherin/rds were grown on glass coverslips,
fixed in MeOH/acetone and incubated with polyclonal antibody to peripherin/rds (C)
followed by incubation with Alexa Fluor 594 secondary antibody. The immunofluorescence
is compared to labeling of mock-transfected (vector alone) MDCK cells labelled with antiXpress (Inset, A) or a polyclonal antibody to peripherin/rds (D).
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Immunofluorescent localization of FLAG tagged wt and C-terminal deletion mutant of
peripherin/rds in transiently transfected MDCK cells. MDCK cells expressing wt FLAGperipherin/rds were grown on glass coverslips, fixed in MeOH/acetone (A, inset mocktransfected), Δ10 FLAG-peripherin/rds mutant (C), Δ50 FLAG-peripherin/rds mutant (D)
were incubated with M5 mAb (anti-FLAG antibody) followed by incubation with Alexa
Fluor 594 secondary antibody. (B) MDCK cells expressing Δ10 FLAG-peripherin/rds
mutant were grown on glass coverslips, fixed in 2 % paraformaldehyde and incubated with
M5 mAb (anti-FLAG antibody) followed by incubation with Alexa Fluor 594 secondary
antibody. Immunofluorescent staining was analysed by laser scanning confocal microscopy.
Optical sections horizontal (X–Y) to the monolayer are shown. Magnification is indicated in
panels.
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Immunolocalization of wt and P296T Xpress-peripherin/rds in transiently transfected
MDCK cells. Cells grown on coverslips were transfected with Xpress-peripherin/rds P296T
mutant, in (A) cells were fixed in MeOH/acetone, incubated with peripherin/rds polyclonal
antibody followed by incubation with Alexa Fluor 594 secondary antibody. (B) Xpressperipherin/rds P296T mutant cells were fixed in 2 % paraformaldehyde, incubated with antiXpress monoclonal antibody followed by incubation with Alexa Fluor 594 secondary
antibody. Inset to (B) Xpress-peripherin/rds P296T mutant expressing cells were incubated
with anti-Xpress antibody prior to fixation with 2 % paraformaldehyde. (C) MDCK cells
transfected with wt Xpressperipherin/rds or (D) mock-transfected cells were fixed in MeOH/
acetone incubated with anti-Xpress monoclonal antibody followed by incubation with Alexa
Fluor 594 secondary antibody. (A) and (C) Insets represent individual cells of each group.
Arrow indicates the location of cell junction. Immunofluorescent staining was analysed by
laser scanning confocal microscopy. Optical sections horizontal (X-Y) to the monolayer are
shown. Magnification is at 63×.
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Western blot analysis of membrane fractions isolated from sucrose density gradients.
Proteins from membrane fractions isolated at 1·02/1·04 g ml−1 interface, designated fraction
1 (1), 1·04/1·.08 g ml−1 interface, designated fraction 2(2), and 1·08/1·125 g ml−1 interface,
designated fraction 3(3) and the pellet fraction (P) were separated by SDS–PAGE and
analysed by Western blot analysis as described in Materials and Methods. The various
fractions 1–3 and P (pellet) are indicated for both Xpress-peripherin/rds cell line 22, mocktransfected MDCK cells (control cells) and the P296T mutant. The immunoreactivity of the
proteins within the fractions with anti-ZO-3 antibody, anti-Xpress antibody and anti-rab 6
antibody is indicated on the right and the respective molecular masses of the proteins
identified in kDa are indicated on the left.
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Fusion between R18-ROS PM and F18 labelled MDCK cell membranes containing wt and
mutant peripherin/rds. Resonance energy transfer from F18 labelled MDCK cell membranes
to R18 labelled ROS PM vesicles upon fusion of the membranes was measured at room
temperature. The results are presented as percentage fusion calculated as described in
Materials and Methods. (A) Time course of fusion between R18 labelled ROS PM vesicles
and F18 labelled wt Xpress-peripherin/rds containing membranes (■), or Δ10 FLAGperipherin/rds deletion mutant ( ), or Δ50 FLAG- peripherin/rds deletion mutant ( ), or
P296T peripherin/rds mutant ( ). (B) Fusion between R18-ROS PM and F18 labelled
membrane fractionated from wt Xpress-peripherin/rds expressing MDCK cells (■), FLAGperipherin/rds Δ10 mutant ( ) and Xpress-peripherin/rds P296T mutant ( ). Fractions were
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isolated as described in Materials and Methods. Fractions 1–3 and pellet are indicated.
Resonance energy transfer from F18 labelled MDCK cell membranes to R18 labelled ROS
PM vesicles upon fusion of the membranes was measured at room temperature. The results
are presented as percentage fusion calculated as described in Materials and Methods. Inset.
The relative amount of expressed protein in fractions 1, 2 and 3 was determined using
Western blot analysis. The Xpress wt and P296T mutant were detected with anti-Xpress and
the 10 FLAG-peripherin/rds mutant with anti-FLAG M5 antibody.
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Fusion between R18-ROS PM and MDCK cell membrane fractions
X-p/rds MDCK cells

Mock-transfected MDCK cells

Target membrane

Additions

IRF

Additions

IRF

Fraction 1

1 μM Ca2+

ND

1 μM Ca2+

ND

Fraction 2

μM Ca2+

0·88 ± 0·02

μM Ca2+

1

μM Ca2+

0·20 ± 0·01

μM Ca2+

1
10 nM PP-5

0·23 ± 0·005

1

Author Manuscript

Fraction 2

1
10 nM PP-5

0·41 ± 0·03

Fraction 2

1 μM Ca2+
10 nM NP-1

0·82 ± 0·03

1 μM Ca2+

0·22 ± 0·009

Fraction 3

1 μM Ca2+

0·65 ± 0·08

1 μM Ca2+

0·11 ± 0·02

Fraction 3

μM Ca2+

1
10 nM PP-5

0·44 ± 0·04

1

μM Ca2+

ND

Fraction 3

1 μM Ca2+
10 nM NP-1

0·69 ± 0·01

1 μM Ca2+

ND

ND

1 μM Ca2+

ND

1

μM Ca2+

ND

1

μM Ca2+

ND

1 uM Ca2+

ND

Pellet
Trypsin treated fraction 2
Trypsin treated fraction 3

1 μM Ca2+
1

μM Ca2+

0·40 ± 0·08

1

μM Ca2+

0·28 ± 0·04

IRF were normalized to total membrane phospholipid in the target membrane. The data shown are the change in fluorescence intensity per min per
umol phospholipid. All assays were carried out at 37°C under dim red light. The target membrane was incubated with either the PP-5 peptide or the
NP-1 peptide for 30 min prior to the initiation of fusion. X-p/rds refers to Xpress-tagged human peripherin/rds. ND, Not detected.
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Fusion between R18-ROS PM and Xpress-peripherin/rds recombinants
Extent of fusion (ΔR × 100)
Target membrane

5 min

10 min

20 min

WT Xp/rds recombinant

15·1 %

23·5 %

26 %

P296T mutant Xp/rds recombinant

40 %

60 %

70 %

The extent of fusion between R18-ROS PM and F18 labeled recombinants was measured as described in Materials and Methods. All assays were
carried out at 37°C under dim red light. Xp/rds refers to Xpress-tagged peripherin/rds isolated from transfected MDCK cells.
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